2023, Number 11
Association between the application of the vaccine and the presence or absence of the COVID-19 disease
Language: Spanish
References: 26
Page:
PDF size: 163.39 Kb.
ABSTRACT
Background: COVID-19 is caused by severe acute respiratory syndrome, this condition caused a large number of deaths, due to these vaccines were developed after analyzing mortality patterns; vaccine efficacy refers to the ability to prevent symptoms, in the studies that were conducted vaccine efficacy was reported showing an effectiveness with 95% CI where Pfizer-BioNTech 95%, AstraZeneca-Oxford 59. 5%, Janssen/Johnson & Johnson 66.1%, Sputnik V 92%, Sinovac 50% and modern 94.1%.Material and Methods: Type of study: observational, analytical, cross-sectional and retrolective with a sample: 352 patients, with a non-probabilistic, non-randomized, convenience sampling, inclusion criteria: patient records with complete vaccination schedule and without vaccination schedule, older than 15 years old. Descriptive statistics were applied with SPSS v25® software.
Results: In the present research work, the association between vaccination history and SARS CoV 2 infection was analyzed regardless of the temporality (pre- or post-vaccination), (p= 0.199).
Conclusions: 74.7% (263 patients) present disease even with complete scheme, while 19.03% (67 patients) present disease without application of the vaccine, in our working hypothesis it was expected that 26% of patients would present disease with complete vaccination scheme, however, our percentage was higher.
REFERENCES
Villar F. Martínez MA, Jiménez D, et al. Recomendaciones SEPAR sobre la vacuna COVID-19 en las enfermedades respiratorias. Open Respiratory Archives [Internet]. 2021 [citado el 01 de mayo de 2023];(3):1-13. doi: 10.1016/j.opresp.2021.100097. Disponible en: http://dx.doi.org/10.1016/j.opresp.2021.100097
Kim JH, Hotez P, Batista C, Ergonul O, Figueroa JP, Gilbert S, et al. Operation Warp Speed: implications for global vaccine security. Lancet Glob Health [Internet]. 2021[citado el 01 de mayo de 2023];9(7):e1017–21. doi: 10.1016/s2214-109x(21)00140-6. Disponible en: http://dx.doi.org/10.1016/s2214-109x(21)00140-6
Thompson MG, Stenehjem E, Grannis S, Ball SW, Naleway AL, Ong TC, et al. Effectiveness of covid-19 vaccines in ambulatory and inpatient care settings. N Engl J Med [Internet]. 2021[citado el 01 de mayo de 2023];385(15):1355–71. doi:10.1056/nejmoa2110362. Disponible en: http://dx.doi.org/10.1056/nejmoa2110362
Sosa-García JO, Gutiérrez-Villaseñor AO, García-Briones A, Romero-González JP, Juárez-Hernández E, González-Chon O. Clinical characteristics of severe COVID-19 patients in an ICU in Mexico. SSRN Electron J [Internet]. 2020 [citado el 01 de mayo de 2023]. doi: 10.2139/ssrn.3605185. Disponible en: http://dx.doi.org/10.2139/ssrn.3605185
Ortiz-Brizuela E, Villanueva-Reza M, González-Lara MF, Tamez-Torres KM, Román-Montes CM, Díaz-Mejía BA, et al. Características clínicas y epidemiológicas de pacientes diagnosticados con COVID-19 en un centro de atención terciaria en la Ciudad de México: Un estudio de cohorte prospectivo. Rev Invest Clin [Internet]. 2020 [citado el 01 de mayo de 2023];72(3). doi: 10.24875/ric.20000211. Disponible en: http://dx.doi.org/10.24875/ric.20000211
Kammar-García A, Vidal-Mayo J de J, Vera-Zertuche JM, Lazcano- Hernández M, Vera-López O, Segura-Badilla O, et al. Impact of comorbidities in Mexican SARS-CoV-2-positive patients: A retrospective analysis in a national cohort. Rev Invest Clin [Internet]. 2020 [citado el 01 de mayo de 2023];72(3). doi: 10.24875/ric.20000207. Disponible en: http://dx.doi.org/10.24875/ric.20000207
Ramírez-Serrano LS, Ilescas-Martínez I, Rosas-Vaquero ZS, Ávila-Ruiz S, Villanueva-Chávez H, Clemente-Herrera A, et al. Alteraciones hidroelectrolíticas en pacientes con infección por SARS-CoV-2 en el servicio de urgencias de un hospital de segundo nivel de la Ciudad de México. Revista de Educación e Investigación en Emergencias [Internet]. 2022 [citado el 01 de mayo de 2023];3(4). doi: 10.24875/reie.21000053. Disponible en: http://dx.doi.org/10.24875/reie.21000053
Zaki N, Alashwal H, Ibrahim S. Asociación de hipertensión, diabetes, accidente cerebrovascular, cáncer, enfermedad renal y colesterol alto con gravedad y muerte de la enfermedad COVID-19: una revisión sistemática. Diabetes Metab Syndr [Internet]. 2020 [citado el 01 de mayo de 2023];14(5):1133–42. doi: 10.1016/j.dsx.2020.07.005. Disponible en: http://dx.doi.org/10.1016/j.dsx.2020.07.005
Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, et al. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: A systemic review and meta-analysis. Research (Wash DC) [Internet]. 2020 [citado el 01 de mayo de 2023];2020. doi: 10.34133/2020/2402961. Disponible en: http://dx.doi.org/10.34133/2020/2402961
Ilescas-Martínez I, Portillo-Delgado EM, Ramírez-Serrano LS, Clemente-Herrera A, Mejía-Monroy M. Descripción Clínica y Epidemiológica de la Asociación de Hipertensión Arterial en Pacientes con COVID-19. Revista Salud y Administración [Internet]. 2021 [citado el 01 de mayo de 2023];8(22):43–55. Disponible en: https://revista.unsis.edu.mx/index.php/saludyadmon/article/view/207
Yan Y, Yang Y, Wang F, Ren H, Zhang S, Shi X, et al. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ Open Diabetes Res Care [Internet]. 2020[citado el 01 de mayo de 2023];8(1):e001343. doi: 10.1136/bmjdrc-2020-001343. Disponible en: http://dx.doi.org/10.1136/bmjdrc-2020-001343